Cerus (CERS) Profit After Tax (2010 - 2026)
Cerus (CERS) reported Profit After Tax of -$1.6 million for Q1 2026, up 78.75% on a YoY basis from -$917491.7 in Q1 2025, and up 24.56% sequentially from -$2.2 million in Q4 2025.
Cerus (CERS) Profit After Tax (2010 - 2026) Analysis & Trends
Cerus (CERS) has 17 years of Profit After Tax data on file, last reported at -$1.6 million in Q1 2026.
- For the quarter ending Q1 2026, Profit After Tax rose 78.75% year-over-year to -$1.6 million; the trailing twelve-month figure through Mar 2026 stood at -$9.5 million (up 49.6% YoY), and the FY2025 full-year result was -$15.6 million, up 25.29% from the prior year.
- Profit After Tax climbed to -$1.6 million in Q1 2026, from -$2.2 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of -$20000.0 in Q3 2025 to a low of -$15.6 million in Q1 2023.
- A 5-year average of -$7.0 million and a median of -$7.3 million in 2023 frame the typical range for Profit After Tax.
- Across the five-year window, Profit After Tax tumbled 69.52% in 2024 and soared 99.32% in 2025, its largest moves.
- Tracing CERS's Profit After Tax over 5 years: stood at -$13.6 million in 2022, then jumped by 89.09% to -$1.5 million in 2023, then plunged by 69.52% to -$2.5 million in 2024, then advanced by 13.7% to -$2.2 million in 2025, then advanced by 24.56% to -$1.6 million in 2026.
- Business Quant data shows CERS's Profit After Tax at -$1.6 million in Q1 2026, -$2.2 million in Q4 2025, and -$20000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.40 Bn | 176.11 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 128.93 Bn | 126.05 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 108.35 Bn | 99.13 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 68.71 Bn | 67.25 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 48.35 Bn | 44.68 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Dexcom | 28.37 Bn | 27.25 Bn | 750.30 Mn | 199.50 Mn |
| 7 | GE HealthCare Technologies | 28.04 Bn | 25.76 Bn | 1.98 Bn | 411.00 Mn |
| 8 | Smith & Nephew | 26.90 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn | 170.93 Mn |
| 10 | Cerus | 602.81 Mn | 522.39 Mn | 27.89 Mn | -1.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.64 Mn |
| Dec 31, 2025 | -2.17 Mn |
| Sep 30, 2025 | -20,000.00 |
| Jun 30, 2025 | -5.72 Mn |
| Mar 31, 2025 | -7.72 Mn |
| Dec 31, 2024 | -2.52 Mn |
| Sep 30, 2024 | -2.93 Mn |
| Jun 30, 2024 | -5.78 Mn |
| Mar 31, 2024 | -9.69 Mn |
| Dec 31, 2023 | -1.49 Mn |
| Sep 30, 2023 | -7.27 Mn |
| Jun 30, 2023 | -13.33 Mn |
| Mar 31, 2023 | -15.64 Mn |
| Dec 31, 2022 | -13.63 Mn |
| Sep 30, 2022 | -8.48 Mn |
| Jun 30, 2022 | -8.40 Mn |
| Mar 31, 2022 | -12.28 Mn |
| Dec 31, 2021 | -9.12 Mn |
| Sep 30, 2021 | -12.44 Mn |
| Jun 30, 2021 | -15.36 Mn |